Researchers have been studying whether certain GLP-1 medications may be associated with a rare condition called non-arteritic anterior ischemic optic neuropathy (NAION), sometimes referred to as an "eye stroke." NAION occurs when blood flow to the optic nerve is reduced, leading to sudden vision loss
injectable BPC-157 if you're deciding between forms
[1] [4] For most individuals, nausea tends to be most pronounced during the first few weeks of therapy , particularly after starting treatment or following a dose increase
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Clinical trials have shown modest reductions in systolic blood pressure (typically 3-7 mmHg, depending on dose and baseline values) and improvements in lipid parameters, particularly triglycerides
The practical translation is straightforward